Provides advanced methodology, state-of-the-art facilities and expertise for both synthesis and analysis of bioactive lipids.
Offers statistical support for the design of studies, analysis of data, quality control and manuscript preparation.
Provides state-of-the-art imaging capabilities at the cellular, tissue, intravital and in vivo whole animal levels.
Provides access to annotated human specimens and tissue microarrays as well as access to expert research pathology and imaging services.
Offers comprehensive analytic flow cytometry and high-speed cell sorting services and the capacity to generate human cellular and tissue-based products for use in research.
If you publish a manuscript including research supported by a HCC Shared Resource, the following text is to be placed in the acknowledgement section: "Supported in part by the [Name] Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313)."
Facilitates the translation of basic science research to the clinical setting and vice-versa with the ultimate intention of improving diagnosis and treatment strategies for cancer patients.
Offers investigators comprehensive analytic flow cytometry and high-speed cell sorting services and the capacity to generate human cellular and tissue-based products for use in translational research.
Offers state-of-the-art next generation sequencing (NGS) including DNA-Seq, RNA-Seq, chromatin immunoprecipitation sequencing (ChIP-Seq), Methyl-Seq, Targeted sequencing utilizing Illumina HiScanSQ and Ion Torrent instrumentation.
Provides scientists access to genome-wide human and mouse libraries that together encode a total of almost 160,000 shRNA clones against over 41,000 genes.
Provides state-of-the-art instrumentation enabling noninvasive anatomical, metabolic, and functional imaging.
Research Cores, shared resources, facilities and centers are available to MUSC researchers, faculty and students.